Loading...
XPARVIRP
Market cap2.68bUSD
Dec 20, Last price  
309.50EUR
1D
-0.80%
1Q
-21.55%
Jan 2017
85.11%
Name

Virbac SA

Chart & Performance

D1W1MN
XPAR:VIRP chart
P/E
21.20
P/S
2.06
EPS
14.60
Div Yield, %
0.43%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
7.49%
Revenues
1.25b
+2.53%
351,404,000372,403,000401,636,000438,548,000443,355,000467,418,000572,830,000623,059,000695,155,000736,080,000773,116,000852,623,000871,828,000861,882,000868,932,000938,342,000934,198,0001,063,964,9991,216,187,0001,246,901,000
Net income
121m
-0.55%
16,726,00019,799,00024,913,00031,873,00036,287,00039,676,00064,313,00058,555,00066,625,00060,523,00063,596,0009,405,00034,646,000-2,575,00020,099,00051,550,000136,039,000113,162,000121,967,000121,298,000
CFO
119m
+20.18%
41,304,00035,764,00048,807,00050,451,00042,280,00064,778,00083,897,00061,781,00097,033,00073,633,00076,447,00046,221,000142,449,000107,806,00083,623,000131,609,000110,221,000126,292,00098,984,000118,957,000
Dividend
Jun 25, 20241.32 EUR/sh
Earnings
Mar 17, 2025

Profile

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
URL
https://corporate.virbac.com/
IPO date
Jan 01, 1985
Employees
5,386
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,246,901
2.53%
1,216,187
14.31%
1,063,965
13.89%
Cost of revenue
824,232
788,916
890,636
Unusual Expense (Income)
NOPBT
422,669
427,271
173,329
NOPBT Margin
33.90%
35.13%
16.29%
Operating Taxes
53,520
45,249
34,640
Tax Rate
12.66%
10.59%
19.99%
NOPAT
369,149
382,022
138,689
Net income
121,298
-0.55%
121,967
7.78%
113,162
-16.82%
Dividends
(11,165)
(10,573)
(6,343)
Dividend yield
0.37%
0.55%
0.18%
Proceeds from repurchase of equity
(19,422)
(14,275)
(9,326)
BB yield
0.64%
0.74%
0.26%
Debt
Debt current
54,491
46,084
52,750
Long-term debt
100,763
45,406
42,624
Deferred revenue
1,450
1,846
1,153
Other long-term liabilities
48,137
58,123
63,408
Net debt
(31,138)
(96,572)
(86,884)
Cash flow
Cash from operating activities
118,957
98,984
126,292
CAPEX
(41,042)
(53,576)
(47,166)
Cash from investing activities
(121,869)
(54,832)
(106,221)
Cash from financing activities
(2,564)
(34,755)
(33,074)
FCF
287,775
295,148
102,699
Balance
Cash
175,906
177,383
172,787
Long term investments
10,486
10,679
9,471
Excess cash
124,047
127,253
129,060
Stockholders' equity
903,383
955,504
832,908
Invested Capital
955,567
825,576
704,216
ROIC
41.45%
49.94%
20.54%
ROCE
38.04%
42.50%
19.62%
EV
Common stock shares outstanding
8,437
8,454
8,448
Price
359.50
57.68%
228.00
-46.29%
424.50
78.36%
Market cap
3,033,178
57.37%
1,927,424
-46.25%
3,585,982
78.59%
EV
3,011,656
1,830,501
3,499,354
EBITDA
470,188
473,087
216,673
EV/EBITDA
6.41
3.87
16.15
Interest
8,882
3,691
5,982
Interest/NOPBT
2.10%
0.86%
3.45%